Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M JAMES

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
Journal of Biopharmaceutical Statistics|March 17, 2007
Issues with statistical risks for testing methods in noninferiority trial without a placebo ARMH M James Hung, Sue-Jane Wang, Robert O'Neill
Therapeutic Innovation & Regulatory Science|September 22, 2018
Comparison of Treatment Effects Between US and Non-US Study Sites in Multiregional Alzheimer Disease Clinical TrialsJingyu Julia Luan, Ranjit Mani, H M James Hung
Journal of Biopharmaceutical Statistics|October 16, 2015
Rejoinder to Dr. Cyrus R. MehtaH M James Hung, Sue-Jane Wang, Peiling Yang
Clinical Physics and Physiological Measurement : an Official Journal of the Hospital Physicists' Association, Deutsche Gesellschaft Fur Medizinische Physik and the European Federation of Organisations for Medical Physics|August 1, 1985
Lead uptake in humans by whole-body counting of 203Pb: assessment of errorsH M James, M E Hilburn, J A Blair
Human Toxicology|July 1, 1985
Effects of meals and meal times on uptake of lead from the gastrointestinal tract in humansH M James, M E Hilburn, J A Blair
Biometrical Journal. Biometrische Zeitschrift|January 7, 2006
A regulatory perspective on choice of margin and statistical inference issue in non-inferiority trialsH M James Hung, Sue-Jane Wang, Robert O'Neill
Statistics in Medicine|August 29, 2012
Paradigms for adaptive statistical information designs: practical experiences and strategiesSue-Jane Wang, H M James Hung, Robert O'Neill
Journal of Biopharmaceutical Statistics|November 21, 2007
Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trialsH M James Hung, Sue-Jane Wang, Robert O'Neill
Biometrical Journal. Biometrische Zeitschrift|April 10, 2009
Challenges and regulatory experiences with non-inferiority trial design without placebo armH M James Hung, Sue-Jane Wang, Robert O'Neill
Journal of Biopharmaceutical Statistics|April 26, 2011
Regulatory perspectives on multiplicity in adaptive design clinical trials throughout a drug development programSue-Jane Wang, H M James Hung, Robert O'Neill
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Journal of Biopharmaceutical Statistics|March 17, 2007
Issues with statistical risks for testing methods in noninferiority trial without a placebo ARMH M James Hung, Sue-Jane Wang, Robert O'Neill
Therapeutic Innovation & Regulatory Science|September 22, 2018
Comparison of Treatment Effects Between US and Non-US Study Sites in Multiregional Alzheimer Disease Clinical TrialsJingyu Julia Luan, Ranjit Mani, H M James Hung
Journal of Biopharmaceutical Statistics|October 16, 2015
Rejoinder to Dr. Cyrus R. MehtaH M James Hung, Sue-Jane Wang, Peiling Yang
Clinical Physics and Physiological Measurement : an Official Journal of the Hospital Physicists' Association, Deutsche Gesellschaft Fur Medizinische Physik and the European Federation of Organisations for Medical Physics|August 1, 1985
Lead uptake in humans by whole-body counting of 203Pb: assessment of errorsH M James, M E Hilburn, J A Blair
Human Toxicology|July 1, 1985
Effects of meals and meal times on uptake of lead from the gastrointestinal tract in humansH M James, M E Hilburn, J A Blair
Biometrical Journal. Biometrische Zeitschrift|January 7, 2006
A regulatory perspective on choice of margin and statistical inference issue in non-inferiority trialsH M James Hung, Sue-Jane Wang, Robert O'Neill
Statistics in Medicine|August 29, 2012
Paradigms for adaptive statistical information designs: practical experiences and strategiesSue-Jane Wang, H M James Hung, Robert O'Neill
Journal of Biopharmaceutical Statistics|November 21, 2007
Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trialsH M James Hung, Sue-Jane Wang, Robert O'Neill
Biometrical Journal. Biometrische Zeitschrift|April 10, 2009
Challenges and regulatory experiences with non-inferiority trial design without placebo armH M James Hung, Sue-Jane Wang, Robert O'Neill
Journal of Biopharmaceutical Statistics|April 26, 2011
Regulatory perspectives on multiplicity in adaptive design clinical trials throughout a drug development programSue-Jane Wang, H M James Hung, Robert O'Neill
Pageof 10